2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide

C21H21F2N3O3S — CID 6598231

IUPAC2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide
SMILESCOC[C@H](C)N1C(=O)[C@H](CC(=O)Nc2ccccc2)S/C1=N\c1ccc(F)cc1F
InChIInChI=1S/C21H21F2N3O3S/c1-13(12-29-2)26-20(28)18(11-19(27)24-15-6-4-3-5-7-15)30-21(26)25-17-9-8-14(22)10-16(17)23/h3-10,13,18H,11-12H2,1-2H3,(H,24,27)/b25-21-/t13-,18-/m0/s1
InChIKeyJJTRYQUNKNZJGR-ZOIPFDPJSA-N
MW433.48 g/mol
LogP3.96
Rot. Bonds7

About 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide

2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide (PubChem CID 6598231) has the molecular formula C21H21F2N3O3S and a molecular weight of 433.48 g/mol. Its IUPAC name is 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide.

Molecular Properties

Compound Name2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide
PubChem CID6598231
Molecular FormulaC21H21F2N3O3S
Molecular Weight433.48 g/mol
Exact Mass433.13
IUPAC Name2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide
SMILESCOC[C@H](C)N1C(=O)[C@H](CC(=O)Nc2ccccc2)S/C1=N\c1ccc(F)cc1F
InChIInChI=1S/C21H21F2N3O3S/c1-13(12-29-2)26-20(28)18(11-19(27)24-15-6-4-3-5-7-15)30-21(26)25-17-9-8-14(22)10-16(17)23/h3-10,13,18H,11-12H2,1-2H3,(H,24,27)/b25-21-/t13-,18-/m0/s1
InChIKeyJJTRYQUNKNZJGR-ZOIPFDPJSA-N
XLogP3.96
TPSA71.00 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500433.48
LogP ≤ 53.96
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide?
The IUPAC name of 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide (CID 6598231) is 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide.
What is the SMILES notation for 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide?
The canonical SMILES for 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide is COC[C@H](C)N1C(=O)[C@H](CC(=O)Nc2ccccc2)S/C1=N\c1ccc(F)cc1F.
What is the InChIKey of 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide?
The InChIKey is JJTRYQUNKNZJGR-ZOIPFDPJSA-N. The full InChI is InChI=1S/C21H21F2N3O3S/c1-13(12-29-2)26-20(28)18(11-19(27)24-15-6-4-3-5-7-15)30-21(26)25-17-9-8-14(22)10-16(17)23/h3-10,13,18H,11-12H2,1-2H3,(H,24,27)/b25-21-/t13-,18-/m0/s1.
What are the key properties of 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide?
2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide has a molecular weight of 433.48 g/mol, XLogP of 3.96, 7 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5S)-2-(2,4-difluorophenyl)imino-3-[(2S)-1-methoxypropan-2-yl]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide is sourced from PubChem (CID 6598231), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).